Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops a platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded by Tarek Hammoud, Stephen M. Malherbe, Oleg Movchan, and Scott Werner in 2006 and is headquartered in Chicago, IL.
Current Value
$10.761 Year Return
Current Value
$10.761 Year Return
Market Cap
$1.02B
P/E Ratio
529.41
1Y Stock Return
16.13%
1Y Revenue Growth
15.51%
Dividend Yield
0.00%
Price to Book
14.0
Double maintains 1 strategies that include ENFN - Enfusion, Inc.
High risk
$8.5K
This strategy concentrates on the technology sector, including companies involved in software, hardware, IT services, and semiconductor industries. It captures the growth potential of tech companies driving innovation and digital transformation, appealing to investors seeking exposure to this dynamic sector.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
288
The stocks that are correlated to ENFN - Enfusion, Inc. are KWR, FELE, OTTR, WTS, U
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
K KWRQuaker Houghton | 39.16% | $1.78B | -46.45% | 1.89% |
37.99% | $3.99B | -12.98% | 1.16% | |
O OTTROtter Tail Corp. | 37.92% | $3.28B | -4.38% | 2.42% |
37.68% | $6.59B | -0.34% | 0.86% | |
36.72% | $7.74B | -20.36% | 0.00% | |
36.62% | $1.37B | -28.89% | 0.00% | |
36.28% | $453.11M | -41.37% | 0.00% | |
36.07% | $3.26B | -1.50% | 4.60% | |
36.06% | $1.86B | -5.01% | 3.37% | |
35.80% | $4.90B | -30.79% | 4.52% | |
K KMPRKemper Corp. | 35.40% | $3.68B | +1.93% | 2.14% |
35.38% | $1.91B | -33.81% | 0.00% | |
V VYXNCR Voyix Corp. | 35.38% | $1.09B | -34.69% | 0.00% |
35.14% | $1.11B | +43.09% | 3.97% | |
T TRUETrueCar, Inc. | 35.06% | $114.65M | -54.36% | 0.00% |
34.93% | $4.71B | -25.36% | 1.71% | |
34.82% | $3.31B | +15.94% | 0.00% | |
34.77% | $1.26B | -24.44% | 5.99% | |
34.69% | $2.28B | +3.72% | 4.64% | |
W WSFSWSFS Financial Corp. | 34.69% | $2.78B | +13.75% | 1.27% |
The ETFs that are correlated to ENFN - Enfusion, Inc. are WCLD, ZIG, XSW, EES, TPSC
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
39.27% | $366.28M | 0.45% | |
38.65% | $32.31M | 0.84% | |
38.60% | $428.23M | 0.35% | |
38.57% | $522.70M | 0.38% | |
37.86% | $173.80M | 0.52% | |
37.78% | $304.68M | 0.68% | |
37.74% | $278.83M | 0.2% | |
37.68% | $350.33M | 0.49% | |
37.60% | $750.02M | 0.6% | |
37.59% | $1.71B | 0.38% | |
37.56% | $10.33B | 0.24% | |
37.55% | $483.46M | 0.2% | |
37.52% | $9.27B | 0.28% | |
37.52% | $57.33B | 0.19% | |
37.51% | $630.66M | 0.4% | |
37.45% | $552.62M | 0.37% | |
37.44% | $10.54B | 0.07% | |
37.44% | $298.69M | 0.79% | |
37.38% | $8.64B | 0.26% | |
37.34% | $2.27B | 0.34% |
Yahoo
BOISE, Idaho & CHICAGO, April 17, 2025--Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater’s acquisition of Enfusion (the "Transaction"). As previously disclosed, the deadline to have made such an election was 5:00 p.m. Eastern Time on A
Yahoo
BOISE, Idaho & CHICAGO, April 02, 2025--Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced that the deadline for Enfusion shareholders of record to elect the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater’s acquisition of Enfusion (the "Transaction") is 5:00 p.m. Eastern Time on April 16, 2025 (such deadline, as it may be extended, the "Election Deadline").
Yahoo
In the United States, the market has experienced a 3.5% decline over the last week, yet it remains up by 5.8% over the past year with earnings expected to grow annually by 14%. In this context of fluctuating yet optimistic growth prospects, identifying high-growth tech stocks involves focusing on companies that demonstrate robust innovation and adaptability in response to evolving market dynamics.
Yahoo
As the U.S. market grapples with volatility amid tariff announcements and economic uncertainty, investors are keenly observing how these factors impact growth stocks. In such an environment, companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those closest to the business in its long-term potential.
Yahoo
Enfusion (ENFN) delivered earnings and revenue surprises of -57.14% and 1.94%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
NEW YORK & LONDON & HONG KONG, March 03, 2025--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds